(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIMAKE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BIMAKE

ST13

US500000087035040

Class

1, 5, 9, 10

Filing

87035040

Registration

6042794

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

64

Latest update

08/04/2026

Trademark type

Word

Nice classes

1, 5, 9, 10

Filing date

05/12/2016

Registration date

04/28/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/04/2026

Last transaction

08/04/2026

Responsible office

United States Patent and Trademark Office

Status code

705

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/01/2017

First use in commerce

12/01/2017

Drawing code

4

Owner type

01

Owner location

Houston, TX, CN

Examiner

WOOD, CAROLINE

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

D. D. (pessoa física)

Representatives

Mark R. Backofen Troutman Pepper Locke LLP

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals for use in industry; biochemicals for use in industry for nonmedical purposes; Reagents for scientific and research usehot start high-fidelity DNA polymerasepolymerase chain reaction reagent (PCR) master mixpolymerase chain reaction reagentsone step synthesized complimentary DNA (cDNA) synthesis master mixquantitative polymerase chain reaction reagent (qPCR) master mixesproteinase inhibitorscell viability assayDNA transfection reagents for scientific and research use; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes

Class 5

Reagents for medical usehot start high-fidelity DNA polymerasepolymerase chain reaction reagent (PCR) master mixespolymerase chain reaction reagentsone step synthesized complimentary DNA (cDNA) synthesis master mixesquantitative polymerase chain reaction reagent (qPCR) master mixesproteinase inhibitorscell viability assaysDNA transfection reagent; nucleic acid isolation and purification kit consisting primarily of reagents for medical use

Class 9

Laboratory instrumentsDNA Microfluidic chip systems comprised of disk-electrophoresis readermulti-lane electrophoresis chipliquid DNA separation gelloading buffer for DNADNA markers; RNA Microfluidic chip systems comprised of disk-electrophoresis readermulti-lane electrophoresis chipliquid RNA separation gelloading buffer for RNARNA markers; Protein Microfluidic chip systems comprised of disk-electrophoresis readermulti-lane electrophoresis chipliquid PRO separation gelloading buffer for proteinprotein markers; Automated Microfluidic electrophoresis chip for Western Blotting; Bioanalyzer apparatus for analyzing protein-protein and protein-small molecule interaction; Electroporator for applying an electrical field to cells to increase the permeability of the cell membranefor introduction of chemicalsdrugsDNA; Automated Microfluidic chip system comprised of multi-lane electrophoresis chipdisk- electrophoresis readerseparation gelloading buffer and markers for molecular cloning and transformation

Class 10

Medical and diagnostic apparatusDNA microfluidic chip systems comprised of multi-lane electrophoresis chipdisk-electrophoresis readerliquid DNA separation gelloading buffer for DNADNA markers for testing DNARNA microfluidic chip systems comprised of multi-lane electrophoresis chipdisk-electrophoresis readerliquid RNA separation gelloading buffer for RNARNA markers for testing RNA all for medical diagnostic use; medical and diagnostic apparatusprotein microfluidic chip systems comprised of multi-lane electrophoresis chipdisk-electrophoresis readerliquid PRO separation gelloading buffer for proteinprotein markers for testing proteinsautomated microfluidic electrophoresis chip for western blottingall for medical diagnostic use

Publications

History of USPTO decisions and trademark events.

64 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/04/2026

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/04/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/27/2026

E815

TEAS SECTION 8 & 15 RECEIVED

04/27/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/10/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/10/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/10/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/10/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/10/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/28/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

04/28/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/27/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/26/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/07/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/06/2020

EX4G

SOU EXTENSION 4 GRANTED

03/06/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/06/2020

IUAF

USE AMENDMENT FILED

02/27/2020

EXT4

SOU EXTENSION 4 FILED

02/27/2020

EEXT

SOU TEAS EXTENSION RECEIVED

02/27/2020

EISU

TEAS STATEMENT OF USE RECEIVED

02/27/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/22/2019

EX3G

SOU EXTENSION 3 GRANTED

08/19/2019

EXT3

SOU EXTENSION 3 FILED

08/19/2019

EEXT

SOU TEAS EXTENSION RECEIVED

08/19/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/29/2019

EX2G

SOU EXTENSION 2 GRANTED

01/25/2019

EXT2

SOU EXTENSION 2 FILED

01/25/2019

EEXT

SOU TEAS EXTENSION RECEIVED

01/25/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/29/2018

EX1G

SOU EXTENSION 1 GRANTED

08/27/2018

EXT1

SOU EXTENSION 1 FILED

08/27/2018

EEXT

SOU TEAS EXTENSION RECEIVED

08/27/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/27/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/02/2018

PUBO

PUBLISHED FOR OPPOSITION

01/02/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/13/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/28/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

11/28/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/28/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

11/28/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/28/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/07/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/07/2017

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

11/07/2017

GNS1

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

10/10/2017

GNCF

CONTINUATION OF FINAL REFUSAL E-MAILED

10/10/2017

CNCF

ACTION CONTINUING A FINAL - COMPLETED

10/10/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/19/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/19/2017

ALIE

ASSIGNED TO LIE

09/13/2017

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/06/2017

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/10/2017

GNFR

FINAL REFUSAL E-MAILED

03/10/2017

CNFR

FINAL REFUSAL WRITTEN

03/10/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/17/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/17/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/17/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/06/2016

GNRT

NON-FINAL ACTION E-MAILED

09/06/2016

CNRT

NON-FINAL ACTION WRITTEN

09/06/2016

DOCK

ASSIGNED TO EXAMINER

08/29/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/17/2016

NWAP

NEW APPLICATION ENTERED

05/16/2016

Continuous trademark protection

Get notified about every new filing that threatens BIMAKE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.